Cognitive Dysfunction, Viral Persistence Studied First in New Long COVID Trials
The first two of the long-awaited long COVID clinical trials from the RECOVER initiative are underway, the NIH said. RECOVER-NEURO, which will study interventions for long COVID cognitive dysfunction, and RECOVER-VITAL, a study targeting viral persistence, are opening enrollment, said Acting NIH Director Lawrence Tabak, DDS, PhD, in a press briefing today. Two other trials, […]